Mostrar el registro sencillo del ítem

dc.contributor.author
Cederquist, Carly T.  
dc.contributor.author
Lentucci, Claudia  
dc.contributor.author
Martinez Calejman, Camila  
dc.contributor.author
Hayashi, Vanessa  
dc.contributor.author
Orofino, Joseph  
dc.contributor.author
Guertin, David  
dc.contributor.author
Fried, Susan K.  
dc.contributor.author
Jeong Lee, Mi  
dc.contributor.author
Cardamone, M. Dafne  
dc.contributor.author
Perissi, Valentina  
dc.date.available
2022-10-21T18:31:11Z  
dc.date.issued
2017-01  
dc.identifier.citation
Cederquist, Carly T.; Lentucci, Claudia; Martinez Calejman, Camila; Hayashi, Vanessa; Orofino, Joseph; et al.; Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue; Elsevier; Molecular Metabolism; 6; 1; 1-2017; 125-137  
dc.identifier.issn
2212-8778  
dc.identifier.uri
http://hdl.handle.net/11336/174419  
dc.description.abstract
Objective Insulin signaling plays a unique role in the regulation of energy homeostasis and the impairment of insulin action is associated with altered lipid metabolism, obesity, and Type 2 Diabetes. The main aim of this study was to provide further insight into the regulatory mechanisms governing the insulin signaling pathway by investigating the role of non-proteolytic ubiquitination in insulin-mediated activation of AKT. Methods The molecular mechanism of AKT regulation through ubiquitination is first dissected in vitro in 3T3-L1 preadipocytes and then validated in vivo using mice with adipo-specific deletion of GPS2, an endogenous inhibitor of Ubc13 activity (GPS2-AKO mice). Results Our results indicate that K63 ubiquitination is a critical component of AKT activation in the insulin signaling pathway and that counter-regulation of this step is provided by GPS2 preventing AKT ubiquitination through inhibition of Ubc13 enzymatic activity. Removal of this negative checkpoint, through GPS2 downregulation or genetic deletion, results in sustained activation of insulin signaling both in vitro and in vivo. As a result, the balance between lipid accumulation and utilization is shifted toward storage in the adipose tissue and GPS2-AKO mice become obese under normal laboratory chow diet. However, the adipose tissue of GPS2-AKO mice is not inflamed, the levels of circulating adiponectin are elevated, and systemic insulin sensitivity is overall improved. Conclusions Our findings characterize a novel layer of regulation of the insulin signaling pathway based on non-proteolytic ubiquitination of AKT and define GPS2 as a previously unrecognized component of the insulin signaling cascade. In accordance with this role, we have shown that GPS2 presence in adipocytes modulates systemic metabolism by restricting the activation of insulin signaling during the fasted state, whereas in absence of GPS2, the adipose tissue is more efficient at lipid storage, and obesity becomes uncoupled from inflammation and insulin resistance.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
ADIPOSE TISSUE  
dc.subject
AKT  
dc.subject
GPS2  
dc.subject
INSULIN  
dc.subject
OBESITY  
dc.subject
UBIQUITIN  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2022-06-21T19:21:47Z  
dc.journal.volume
6  
dc.journal.number
1  
dc.journal.pagination
125-137  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
New York  
dc.description.fil
Fil: Cederquist, Carly T.. University Of Boston. School Of Medicine.; Estados Unidos  
dc.description.fil
Fil: Lentucci, Claudia. University Of Boston. School Of Medicine.; Estados Unidos  
dc.description.fil
Fil: Martinez Calejman, Camila. University Of Massachussets. Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Hayashi, Vanessa. University Of Boston. School Of Medicine.; Estados Unidos  
dc.description.fil
Fil: Orofino, Joseph. University Of Boston. School Of Medicine.; Estados Unidos  
dc.description.fil
Fil: Guertin, David. University Of Massachussets. Medical School; Estados Unidos  
dc.description.fil
Fil: Fried, Susan K.. Icahn School of Medicine at Mount Sinai; Estados Unidos  
dc.description.fil
Fil: Jeong Lee, Mi. University of Boston. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Cardamone, M. Dafne. University of Boston. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Perissi, Valentina. University Of Boston. School Of Medicine.; Estados Unidos  
dc.journal.title
Molecular Metabolism  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.molmet.2016.10.007  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2212877816302101